Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.70
Bid: 3.66
Ask: 3.70
Change: -0.10 (-2.63%)
Spread: 0.04 (1.093%)
Open: 3.70
High: 3.70
Low: 3.70
Prev. Close: 3.80
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of new Board Directors

30 Oct 2019 07:00

RNS Number : 5438R
Plant Health Care PLC
30 October 2019
 

30 October 2019

Plant Health Care plc

("Plant Health Care" or the "Company")

Appointment of new Board Directors

Plant Health Care is pleased to announce three new Board appointments with effect from 1st November 2019.

 

Mr Guy van Zwanenberg FCA will join the PHC Board as a Non-executive Director. He will take over as Chair of the Audit Committee and will hold the position of Senior Independent Director. Guy has had a distinguished career as a chartered accountant and finance director and company secretary of listed and unlisted companies. He sits on a number of company boards, including as non-executive chairman of SmartSpace Software plc, and non-executive director of Quixant plc.

 

Mr Jeffrey Hovey will join the Board as an Executive Director. Jeff Hovey will continue as the Company's Chief Financial officer, a post he has held since 2013.

 

Mr Jeffrey Tweedy will join the Board as an Executive Director. Jeff Tweedy will continue as Chief Operating Officer, a post he has held since 2018. Previous to that, he was Commercial Lead, Americas.

 

Further background details of new Directors and revised membership of Board committees will be accessible on the Company's website.

 

Richard Webb, Non-executive Chairman, commented: "We warmly welcome Guy to the Board, where he will bring a wealth of relevant experience. The addition of Jeff Hovey and Jeff Tweedy will ensure that the Board is deeply grounded in the execution of our strategy and will help Chris Richards, the CEO, to drive performance."

 

 

The following details in relation to the appointment of Mr Guy van Zwanenberg (aged 65) are disclosed in accordance with Schedule 2(g) of the AIM Rules:

 

Current directorships / partnerships

Directorships / partnerships within the last five years

VZ Limited

ICE Marketing Limited

Wargrave and Shiplake Regatta Limited

The Powder Byrne Group Limited

Quixant Limited

Powder Byrne International Limited

Smartspace Software plc

Fast Lane Consulting and Education Services Limited

 

Fast Lane Consulting and Education Services Limited (Ireland)

 

Thoughts to Treasure Limited

 

Gamingking Limited

 

Mr van Zwanenberg does not hold any shares or options in the Company.

 

There is no further information to be disclosed in relation to Mr van Zwanenberg's appointment pursuant to AIM Rule 17 or paragraph (g) of Schedule Two of the AIM Rules for Companies.

 

 

The following details in relation to the appointment of Mr Jeffrey Hovey (aged 51) are disclosed in accordance with Schedule 2(g) of the AIM Rules:

 

Mr Hovey has an interest of nil ordinary shares ("Ordinary Shares") in the capital of Plant Health Care and holds options of 1,028,870 exercisable at a range of 20 - 25 pence per Ordinary Share. The options are exercisable up to 10 years from his commencement and the vesting period ranges from immediate to 3 years.

 

There is no further information to be disclosed in relation to Mr Hovey's appointment pursuant to AIM Rule 17 or paragraph (g) of Schedule Two of the AIM Rules for Companies.

 

 

The following details in relation to the appointment of Mr Jeffrey Tweedy (aged 52) are disclosed in accordance with Schedule 2(g) of the AIM Rules:

 

Mr Tweedy has an interest of 17,904 ordinary shares of 20 pence each ("Ordinary Shares") in the capital of Plant Health Care and holds options of 1,229,359 exercisable at 24 pence per Ordinary Share. The options are exercisable up to 10 years from his commencement and the vesting period ranges from immediate to 3 years.

 

There is no further information to be disclosed in relation to Mr Tweedy's appointment pursuant to AIM Rule 17 or paragraph (g) of Schedule Two of the AIM Rules for Companies.

 

 

For further information, please contact:

 

Plant Health Care plc

Richard Webb, Non-executive Chairman Tel: +1 919 926 1600

 

 

Arden Partners plc - Broker and NomadJohn Llewellyn-Lloyd / Dan Gee-Summons (Corporate Finance) Tel: +44 (0) 20 7614 5900

Fraser Marshall (Equity Sales)

 

Company website: www.planthealthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUKVRRKOARUUA
Date   Source Headline
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments
12th Jan 20237:00 amRNSNovozymes Distribution Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.